Aion Therapeutic Inc. (AION.CN)
CAD 0.01
(0.0%)
CAD 0.01
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -41.39 Thousand | -1.34 Million | -2.13 Million | -551.75 Thousand | -1.31 Million | -332.87 Thousand |
| Net Income | -256.65 Thousand | -3.81 Million | -8.26 Million | -672.83 Thousand | -4.93 Million | -140.11 Thousand |
| Depreciation & Amortization | 17.3 Thousand | 65.29 Thousand | 128.13 Thousand | 111.05 Thousand | - | - |
| Deferred income taxes | - | -451.6 Thousand | 5.15 Million | - | - | - |
| Stock-based compensation | - | 451.6 Thousand | 451.6 Thousand | - | 554.83 Thousand | 1.6 Million |
| Change in working capital | 752.53 Thousand | 1.33 Million | 227.16 Thousand | 272.43 Thousand | -133.05 Thousand | -116.4 Thousand |
| Other non-cash items | -554.57 Thousand | 1.06 Million | 167.97 Thousand | -262.41 Thousand | 3.19 Million | -76.34 Thousand |
| Investing Cash Flow | 135.18 Thousand | -1.38 Million | -1.38 Million | -333.19 Thousand | -2.01 Million | 14.06 Thousand |
| Investments in PPE | -3.00 | -1.44 Million | -1.44 Million | -204.62 Thousand | -1.95 Million | - |
| Acquisitions | 135.18 Thousand | - | - | - | 1757.00 | 14.06 Thousand |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 135.18 Thousand | 64.81 Thousand | 64.81 Thousand | -128.56 Thousand | -64.81 Thousand | - |
| Financing Cash Flow | 163.24 Thousand | 1.19 Million | 3 Million | -125 Thousand | -286.14 Thousand | 317.23 Thousand |
| Debt repayment | -174.34 Thousand | -565.77 Thousand | -273.67 Thousand | -125 Thousand | -105 Thousand | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 100 Thousand | 1.11 Million | 2.94 Million | - | 5000.00 | - |
| Other Financing Activities | 237.59 Thousand | 651.07 Thousand | 330.67 Thousand | -253.56 | -181.14 Thousand | 317.23 Thousand |
| Accounts receivables | -54.89 Thousand | -77.48 Thousand | 2127.00 | 247.95 Thousand | -199.45 Thousand | -9972.00 |
| Accounts payables | - | - | 423.77 Thousand | 4901.00 | 46.05 Thousand | - |
| Inventory | - | - | -425.9 Thousand | - | - | - |
| Other working capital | 807.42 Thousand | 1.41 Million | 227.16 Thousand | 19.58 Thousand | 20.34 Thousand | -106.43 Thousand |
| Cash at beginning of period | - | 239.82 Thousand | 612.78 Thousand | 1.62 Million | 5.24 Million | 15.9 Thousand |
| Cash at end of period | 336.00 | 239.82 Thousand | 239.82 Thousand | 612.78 Thousand | 1.62 Million | 269.00 |
| Capital Expenditure | -3.00 | -1.44 Million | -1.44 Million | -204.62 Thousand | -1.95 Million | - |
| Effect of forex changes on cash | -256.7 Thousand | -90.25 Thousand | 138.32 Thousand | 1 Million | 3.61 Million | - |
| Net cash flow / Change in cash | 336.00 | - | -372.95 Thousand | -1 Million | -3.61 Million | -15.63 Thousand |
| Free Cash Flow | -41.4 Thousand | -2.79 Million | -3.57 Million | -756.37 Thousand | -3.26 Million | -332.87 Thousand |
| Breakdown | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 FY | 2022 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -377.95 Thousand | -181.35 Thousand | -328.58 Thousand | -723.45 Thousand | -256.65 Thousand | -215.72 Thousand |
| Depreciation & Amortization | 14.97 Thousand | - | - | 126.00 | 17.3 Thousand | 5836.00 |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 556.07 Thousand | 108.3 Thousand | 58.54 Thousand | 231.82 Thousand | 752.53 Thousand | 184.4 Thousand |
| Other non-cash items | 50.14 Thousand | 29.24 Thousand | 34.44 Thousand | 643.06 Thousand | -554.57 Thousand | -94.29 Thousand |
| Investing Cash Flow | -23.36 Thousand | -201.28 Thousand | -64.77 Thousand | - | 135.18 Thousand | 135.18 Thousand |
| Investments in PPE | 2.00 | - | - | - | - | - |
| Acquisitions | - | - | - | - | 135.18 Thousand | 135.18 Thousand |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -23.36 Thousand | -201.28 Thousand | -64.77 Thousand | - | 135.18 Thousand | 135.18 Thousand |
| Financing Cash Flow | 48.7 Thousand | 387.5 Thousand | 155 Thousand | 860.00 | 163.24 Thousand | -123.29 Thousand |
| Debt repayment | -34.19 Thousand | - | - | -140.00 | -174.34 Thousand | -141.68 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 387.5 Thousand | 155 Thousand | 100 Thousand | 100 Thousand | - |
| Other Financing Activities | 25.94 Thousand | -155 Thousand | 155 Thousand | -99 Thousand | 237.59 Thousand | 18.38 Thousand |
| Accounts receivables | -43.75 Thousand | 15.26 Thousand | 157.67 Thousand | -19.13 Thousand | -54.89 Thousand | -6635.00 |
| Accounts payables | 52.18 Thousand | - | - | - | - | - |
| Inventory | -52.18 Thousand | - | - | - | - | - |
| Other working capital | 599.83 Thousand | 93.03 Thousand | -99.12 Thousand | 250.95 Thousand | 807.42 Thousand | 191.04 Thousand |
| Cash at beginning of period | 926.00 | 33.92 Thousand | 336.00 | - | - | 13.47 Thousand |
| Cash at end of period | 349.28 Thousand | 926.00 | 33.92 Thousand | 336.00 | 336.00 | -135.18 Thousand |
| Capital Expenditure | 2.00 | - | - | - | - | - |
| Effect of forex changes on cash | 79.77 Thousand | -175.39 Thousand | 178.94 Thousand | -152.08 Thousand | -256.7 Thousand | 94.4 Thousand |
| Net cash flow / Change in cash | 348.35 Thousand | -32.99 Thousand | 33.58 Thousand | 336.00 | 336.00 | -148.65 Thousand |
| Free Cash Flow | 243.24 Thousand | -43.81 Thousand | -235.58 Thousand | 151.56 Thousand | -41.39 Thousand | -119.77 Thousand |
NXCLF
TSO
SBAC
FDLPF
MOIL
COCE3